| abstract |
PROBLEM TO BE SOLVED: To provide an improved mycoplasma hyopneumoniae bacterin vaccine composition that conveniently provides immunization from infection after a single administration. The present application provides inactivated immunization from a Mycoplasma hyopneumoniae bacterin and in combination with an inactivated Mycoplasma hyopneumoniae bacterin, and specific for the Mycoplasma hyopneumoniae bacterin And an adjuvant mixture that elicits an immunization response, including cell-mediated immunization and local (secretory IgA) immunization. [Selection figure] None |